[1]
Di Napoli, M. et al. 2022. Nivolumab–ipilimumab in renal cell carcinoma metastatic to the bones: A case report. Acta Biomedica Atenei Parmensis. 93, S1 (Jun. 2022), e2022132. DOI:https://doi.org/10.23750/abm.v93iS1.12876.